A. Wong

Safety and Efficacy of Chop for Treatment of Diffuse Large B-Cell Lymphoma with Different Combination Antiretroviral Therapy Regimens: Sculpt Study

D. Rouleau, J. Routy, V. Kukreti, 2013, Antiviral therapy.

Glycemic Control after Initiating Direct-Acting Antiviral Agents in Patients with Hepatitis C Virus and Type 2 Diabetes Mellitus Using the United States Integrated Healthcare System

N. Rashid, Angela X. Chen, Joanie Chung, 2020, Journal of research in pharmacy practice.

Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update.

R. Dillman, Antonio J. Grillo-López, M. Benyunes, 2000, Seminars in oncology.

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

O. Frankfurt, S. Kambhampati, H. Kantarjian, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antiretroviral-Chemotherapy Interactions: CVP regimen

A. Wong, 2013 .

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.

O. Frankfurt, F. Ravandi, J. Pagel, 2018 .

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

S. Kambhampati, H. Kantarjian, T. Kadia, 2018, Blood.